Boston scientific announces agreement to acquire silk road medical, inc.

Acquisition adds innovative technology for stroke prevention to vascular portfolio marlborough, mass. , june 18, 2024 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced it has entered into a definitive agreement to acquire silk road medical, inc. (nasdaq: silk), a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (tcar).
BSX Ratings Summary
BSX Quant Ranking